Clinical Trials Browser

Phase 2 × Stomach Neoplasms × tusamitamab ravtansine × Clear all

NCT05703555 2024-02-28

INTRUSION

Phase 2 Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms